The Minister, who set up a working group last week after publishing a two-year old report that found more than a third of all new drug approvals take more than two years to complete compared to the six-month window expected said he wanted to see a more transparent drug approvals process and improved timelines.
The Minister hailed the dramatic increase in funding for new medicines under the current Government, over the past two years, including 35 orphan drugs – therapies for rare diseases or ones where no treatment is available.
He also spoke about the multispecificity of modern drugs, using the example of an obesity therapy his company is currently developing, known as AMG133 that is designed to slow the pace of the gastric process and glucose production as well as the formation of fat cells while increasing the feeling of being full and the secretion of insulin.#
IrishTimes Drug companies listening to one of the smallest health services in the world